ArticleAntibiotics (Basel, Switzerland)2026

Targeting WHO-Priority MDR and XDR Gram-Negative Ocular Isolates by Combining Conventional Antimicrobials with Membrane-Active Peptides.

Teshome Belachew Eshete et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.